Literature DB >> 9802278

Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group.

C B Lücking, N Abbas, A Dürr, V Bonifati, A M Bonnet, T de Broucker, G De Michele, N W Wood, Y Agid, A Brice.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9802278     DOI： 10.1016/s0140-6736(05)60746-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  30 in total

1.  Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.

Authors:  M Periquet; C Lücking; J Vaughan; V Bonifati; A Dürr; G De Michele; M Horstink; M Farrer; S N Illarioshkin; P Pollak; M Borg; C Brefel-Courbon; P Denefle; G Meco; T Gasser; M M Breteler; N Wood; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  2001-02-14       Impact factor: 11.025

2.  Parkin transcript variants in rat and human brain.

Authors:  Velia Dagata; Sebastiano Cavallaro
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 3.  Genetics of Parkinson disease.

Authors:  Nathan Pankratz; Tatiana Foroud
Journal:  NeuroRx       Date:  2004-04

4.  Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.

Authors:  Briana R De Miranda; Emily M Rocha; Qing Bai; Amina El Ayadi; David Hinkle; Edward A Burton; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2018-04-09       Impact factor: 5.996

5.  Parkin Deficiency Reduces Hippocampal Glutamatergic Neurotransmission by Impairing AMPA Receptor Endocytosis.

Authors:  Giuseppe P Cortese; Mei Zhu; Damian Williams; Sarah Heath; Clarissa L Waites
Journal:  J Neurosci       Date:  2016-11-30       Impact factor: 6.167

Review 6.  Parkin and mitophagy in cancer.

Authors:  J P Bernardini; M Lazarou; G Dewson
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

7.  Genetic analysis of neurodegenerative diseases in a pathology cohort.

Authors:  Cornelis Blauwendraat; Olga Pletnikova; Joshua T Geiger; Natalie A Murphy; Yevgeniya Abramzon; Gay Rudow; Adamantios Mamais; Marya S Sabir; Barbara Crain; Sarah Ahmed; Liana S Rosenthal; Catherine C Bakker; Faraz Faghri; Ruth Chia; Jinhui Ding; Ted M Dawson; Alexander Pantelyat; Marilyn S Albert; Mike A Nalls; Susan M Resnick; Luigi Ferrucci; Mark R Cookson; Argye E Hillis; Juan C Troncoso; Sonja W Scholz
Journal:  Neurobiol Aging       Date:  2018-11-17       Impact factor: 4.673

Review 8.  Genetics of parkin-linked disease.

Authors:  Andrew B West; Nigel T Maidment
Journal:  Hum Genet       Date:  2004-01-15       Impact factor: 4.132

9.  Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.

Authors:  N Pankratz; D K Kissell; M W Pauciulo; C A Halter; A Rudolph; R F Pfeiffer; K S Marder; T Foroud; W C Nichols
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.